Dawn Halkuff

Entity
Individual
Business address
C/O Xeris Pharmaceuticals, 180 N. Lasalle St., Ste. 1800, 60601 Chicago, IL
Insider ownership signature
/s/ Beth Hecht, Attorney-in-Fact
All SEC filings
View on sec.gov
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Dawn Halkuff has filed 14 SEC EDGAR filings since 6/20/2018

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 Aug 13, 2025 Aug 12, 2025 001-40880
144 Open Document Open Filing Aug 12, 2025
4 Open Document Open Filing FORM 4 Jun 4, 2025 Jun 4, 2025 001-40880
4 Open Document Open Filing FORM 4 Jun 5, 2024 Jun 5, 2024 001-40880
4 Open Document Open Filing FORM 4 Nov 21, 2023 Nov 20, 2023 001-40880
4 Open Document Open Filing FORM 4 Jun 7, 2023 Jun 7, 2023 001-40880
4 Open Document Open Filing FORM 4 Jun 9, 2022 Jun 8, 2022 001-40880
4 Open Document Open Filing FORM 4 SUBMISSION Oct 5, 2021 Oct 5, 2021 001-40880
4 Open Document Open Filing FORM 4 SUBMISSION Oct 5, 2021 Oct 5, 2021 001-38536
3 Open Document Open Filing FORM 3 Oct 5, 2021 Oct 5, 2021 001-40880
4 Open Document Open Filing FORM 4 Jun 8, 2021 Jun 8, 2021 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION Jun 4, 2020 Jun 4, 2020 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION Mar 1, 2019 Feb 27, 2019 001-38536
3 Open Document Open Filing FORM 3 SUBMISSION Jun 20, 2018 Jun 20, 2018 001-38536